2024 - Biennial Meeting of the Neurotoxicity Society

Mercure Hotel Rio Vermelho

Salvador Bahia Brazil


SCIENTIFIC PROGRAM


Opening Lecture: ● Rita Raisman-Vozari (Paris Brain Institute, University of

Sorbonne, France) - How serendipity remains a powerful tool in the discovery of

neuroprotective drugs.

Tribute to Arne Schousboe - Marta Antonelli

Symposium I –Mechanisms on Neurotoxicity I. Chair: Marta Antonelli

● Thaís Antonia Alves Fernandes (University of São Paulo-RP, Brazil) - Neuroprotective

effect against aggregation of phosphorylated tau protein from non-antibiotic

tetracyclines derivatives in primary culture of cortical neurons

● Jordi Duran (University of Chile, Chile) – Glycogen-induced neurotoxicity.

● Marta Antonelli (University of Buenos Aires, Argentina) -Longitudinal study of the effect

of gestational stress on the newborn and its subsequent neurodevelopment.


Symposium II – Mechanisms on Neurotoxicity II. Chair: Pablo Caviedes

● Karen Renata Herculano Matos Oliveira (Federal University of Pará, Brazil) -

Neurocognitive impacts of severe malaria: mechanism of action and preclinical

evaluation of bioactive compounds.

● Andrea Paula Lima (University of Chile, Chile) - Role of endoplasmic reticulum-mediated

calcium signaling in the toxicity of Alzheimer's disease-related amyloid-beta peptide

oligomers.10

● Pablo Caviedes (University of Chile, Chile) - P21 Activated kinase (PAK) as a

therapeutical target in Down syndrome neuronal dysfunction: Effect on cell process

formation and emission.

● Patrícia Fernanda Schuck (Federal University of Rio de Janeiro, Brazil) – Galactose

neurotoxicity in galactosemia experimental models.


10/09/2024

Symposium III –Neurotoxicity and Neuroprotection I. Chair: Gustavo Ferreira

● Francisco Guimarães (University of São Paulo-RP, Brazil) – Cannabidiol in Psychosis.

● Glauce Crivelaro do Nascimento (University of São Paulo, Brazil) – Anti-nociceptive

effects of non-antibiotic derivatives of demeclocycline and doxycycline against formalin-

induced pain stimulation.

● Gustavo Ferreira (Federal University of Rio de Janeiro, Brazil) – “Not so” neuroprotective

effect of carnosine.

 Symposium IV – Neurotoxicity and Neuroprotection II. Chair: Victor Diogenes

A.l da Silva

● Andrea Paula Lima (University of Chile, Chile) - The detrimental role of calcium signaling

in Alzheimer’ disease amyloid pathology.

● Henning Ulrich (University of São Paulo, Brazil) - Purinergic signaling in neurotoxin-

induced dopaminergic degeneration.

● Victor Diogenes (Federal University of Bahia, Brazil) - Molecular mechanisms in

Parkinson’s disease and potential use of flavonoid rutin.

Symposium V- Control of Neuroinflammation in Brain Diseases - Chair: Elaine

Del Bel

● Bianca Andretto de Mattos (University of São Paulo-RP, Brazil) - The physiological

antioxidant uric acid and the non-antibiotic derivative of oxytetracycline, DOT, reduce

pathological tau abnormalities induced by low-level oxidative injuries.

● Rommy Von Bernhardi Montgomery (University San Sebastian, Chile) - Microglial cell11

regulation changes in aging and neurodegenerative disease.

● Alexandre Amaral (University of Rio Grande do Sul, Brazil) - Protective role of PPAR

activation on D-2-hydroxyglutaric acid neurotoxicity in vivo.

● Elaine Del-Bel (University of São Paulo-RP, Brazil) - Cannabidiol and Cannabigerol limit

L-DOPA-induced dyskinesia when given separately or in combination to

hemiparkinsonian rats.

Poster Session

11/09/2024

Symposium VI -Neuron glia interaction in health and disease. Chair: Silvia Costa

● Silvia Oliveira Bravo (Biological Research Institute Clemente Estable, Uruguay) Synthetic

chalcones to prevent white matter disease.

● Patricia Cassina (University de la Republica, Uruguay) - Glial reactivity and mitochondrial

modulation in chronic pain.

● Coral Sanfeliu (Institute of Biomedical Research of Barcelona, Spain) - High prenatal

levels of epoxyeicosatrienoic acids protect against developmental neurotoxicity and

neurodegenerative injuries.

Closing Conference: Moacir Wajner (Federal University of Rio Grande do Sul,

Brazil) - Organic acid neurotoxicity and the pathogenesis of organic acidemias.



Meeting program

Neurotoxicity Society Virtual Meeting 2021


June 17-18

Day 1
Welcome (NTS President and Program Committee)
Session I:

MPTP intoxication in the Octodon degus: effects on the nigrostriatal pathway and related areas.

Lorena Cuenca-Bermejo (Mentor: Maria Trinidad Herrero)


Early changes in epigenetics and oxidative stress in Old Parkinsonian mice.

Pablo Gallo-Soljancic. (Mentor: Maria Trinidad Herrero)


Study of the anti-inflammatory and neuroprotective effect of flavonoid rutin in a pre-clinical model of Parkinson’s disease induced by aminochrome.

Fillipe Mendes De Araújo (Mentor: Victor Diogenes Amaral Silva)


Discussion (Chair: María Trinidad Herrero)


Cannabidiol attenuates non-motor symptoms in parkinsonian rats.

Bianca Andretto de Mattos (Mentor: Maria M. Weffort de Oliveira)


Effects of ethyl-acetate fraction of Trichilia catigua on memory and oxidative stress after cerebral ischemia: An analysis of the time window of efficacy.

Daniela Velasquez de Oliveira (Mentor: Humberto Milani)


Discussion (Chair: Harry Steinbusch)


Session II

Different short-predictable stress in juvenile rats have no long-lasting effects on the volume of corpus callosum, hippocampus neither anxiety-like behavior or object recognition memory.

Lucas Brunati Gremaschi. (Mentor: Silvana Regina de Melo)


ALDH2 inhibition by Lead and Ethanol co-exposure: impact on bioenergetics and oxidative stress biomarkers in SH-SY5Y cells.

Romina Deza-Ponzio (Mentor: Miriam B. Virgolini)


Changes of plasma PACAP-38 level in patients with Parkinson’s disease .

Daniel Pham (Mentor: Andrea Tamas)


Modeling Parkinson´s Disease with AAV viral particles and human PFFs of α-Syn .

Mónica Gómez-Benito (Mentor: Rosario Moratalla)


Discussion (Chair: Elaine del Bel)


Day 2

Session III:

 Increased expression of DSCAM and its action on neuronal morphological parameters in immortalized cell models of Down Syndrome. Possible role of the PAK effector pathway.

Ramón Pérez-Núñez (Mentor: Pablo Caviedes)


Evaluation of the impact of amyloid precursor protein (APP) and P21-activated kinase (PAK) on the morphological parameters in murine trisomy 16 neuronal cell lines, an animal model of Down syndrome.

Natalia Barraza (Mentor: Pablo Caviedes)


Neuron glial antigen 2 in the striatum of parkinsonian rats presenting L-DOPA induced dyskinesia.

Nascimento G.C (Mentor: Elaine Del-Bel).


LPS-Induced Inflammatory Reaction In Microglial Cells Is Prevented By Cannabidiol Through A Glucose Uptake-Dependent Oxidative Stress Mechanism.

Maurício Dos-Santos-Pereira (Mentor:  Elaine Del Bel)


Discussion (Chair: Pablo Caviedes)


Open debate about neurotoxicity and current strategies